Gaskill Christa F, Carrier Erica J, Kropski Jonathan A, Bloodworth Nathaniel C, Menon Swapna, Foronjy Robert F, Taketo M Mark, Hong Charles C, Austin Eric D, West James D, Means Anna L, Loyd James E, Merryman W David, Hemnes Anna R, De Langhe Stijn, Blackwell Timothy S, Klemm Dwight J, Majka Susan M
Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine or Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee USA.
Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA.
J Clin Invest. 2017 Jun 1;127(6):2262-2276. doi: 10.1172/JCI88629. Epub 2017 May 2.
Pulmonary vascular disease is characterized by remodeling and loss of microvessels and is typically attributed to pathological responses in vascular endothelium or abnormal smooth muscle cell phenotypes. We have challenged this understanding by defining an adult pulmonary mesenchymal progenitor cell (MPC) that regulates both microvascular function and angiogenesis. The current understanding of adult MPCs and their roles in homeostasis versus disease has been limited by a lack of genetic markers with which to lineage label multipotent mesenchyme and trace the differentiation of these MPCs into vascular lineages. Here, we have shown that lineage-labeled lung MPCs expressing the ATP-binding cassette protein ABCG2 (ABCG2+) are pericyte progenitors that participate in microvascular homeostasis as well as adaptive angiogenesis. Activation of Wnt/β-catenin signaling, either autonomously or downstream of decreased BMP receptor signaling, enhanced ABCG2+ MPC proliferation but suppressed MPC differentiation into a functional pericyte lineage. Thus, enhanced Wnt/β-catenin signaling in ABCG2+ MPCs drives a phenotype of persistent microvascular dysfunction, abnormal angiogenesis, and subsequent exacerbation of bleomycin-induced fibrosis. ABCG2+ MPCs may, therefore, account in part for the aberrant microvessel function and remodeling that are associated with chronic lung diseases.
肺血管疾病的特征是微血管重塑和丧失,通常归因于血管内皮的病理反应或异常的平滑肌细胞表型。我们通过定义一种调节微血管功能和血管生成的成年肺间充质祖细胞(MPC),对这一认识提出了挑战。目前对成年MPC及其在稳态与疾病中作用的理解受到缺乏遗传标记的限制,这些标记可用于谱系标记多能间充质并追踪这些MPC向血管谱系的分化。在这里,我们表明,表达ATP结合盒蛋白ABCG2(ABCG2+)的谱系标记肺MPC是周细胞祖细胞,参与微血管稳态以及适应性血管生成。Wnt/β-连环蛋白信号的激活,无论是自主激活还是在BMP受体信号降低的下游激活,都会增强ABCG2+ MPC的增殖,但会抑制MPC分化为功能性周细胞谱系。因此,ABCG2+ MPC中增强的Wnt/β-连环蛋白信号驱动了持续性微血管功能障碍、异常血管生成以及随后博来霉素诱导的纤维化加重的表型。因此,ABCG2+ MPC可能部分解释了与慢性肺病相关的微血管功能异常和重塑。